Eli Lilly and Co. and Purdue University announce a $250 million investment to continue to accelerate pharmaceutical innovation and boost Indiana's economy.

Because price and margin headwinds exist predominantly in small-molecule oral tablets that are easy to produce, we expect Viatris’ future pipeline to focus more on complex generics—drugs that have ...

BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher ...

TPG Growth, TPG’s middle market and growth equity platform, is funding the investment, along with Novo Holdings as a ...

With only about $1.6 billion in debt in December 2024 compared with $0.3 billion in cash and investments, Waters maintains a financially flexible balance sheet with net leverage around 1 time. Waters ...

U.S. pharmaceutical companies are increasingly licensing new drugs from China. Former FDA Commissioner Scott Gottlieb ...

The following column is by Goldwater President and CEO Victor Riches.

New research from Bayes Business School, in collaboration with biopharmaceuticals company Merck KGaA, suggests member states ...

Trump hosted top CEOs at the White House to announce over $8 trillion in U.S. investments. From AI chips to steel, here’s who ...

Regulus Therapeutics will be acquired by Novartis AG for $7 per share in cash. Click here for more information on RGLS ...

After developing treatments for rare tumors, SpringWorks Therapeutics is taking a buyout offer from Germany-based Merck KGaA.

Merck, the New Jersey-based drug giant that started in Philadelphia and is Montgomery County’s largest private employer, is investing nearly $1 billion in a new factory and lab development at DuPont ...